Literature DB >> 9755903

Correlation of plasma clearance of 54 extensively metabolized drugs between humans and rats: mean allometric coefficient of 0.66.

W L Chiou1, G Robbie, S M Chung, T C Wu, C Ma.   

Abstract

PURPOSE: To evaluate the distribution of allometric exponents for relationship of total plasma clearance of 54 extensively metabolized drugs, with wide-ranging linear clearance values, between humans and rats, to provide a rationale for the observed data, and to discuss potential significance of the findings.
METHODS: Human and rat plasma clearance values of 54 drugs with markedly different physicochemical properties were obtained from the literature. Standard allometric analysis was performed for each drug using both rat and human data. Unbound vs. total plasma clearances were obtained for 15 out of 54 drugs and their correlations between humans and rats were compared.
RESULTS: The mean+/-SD of the allometric exponent for the 54 drugs studied is 0.660+/-0.190. The median clearance ratio based on unit body weight is 7.41 and the median exponent is 0.645. Excluding two outliers the correlation coefficient of plasma clearance between humans and rats was 0.745 (p < 0.0001). For the 15 drugs, use of unbound plasma clearance approach seems to significantly improve the correlation coefficient compared to total plasma clearance (0.940 vs. 0.841).
CONCLUSIONS: The present study indicates that on average, humans and rats may eliminate extensively metabolized drugs at a rate similar to that expected from the allometric or body surface area relationship of basal metabolic rate between the two species. A simple statistical distribution hypothesis is used to rationalize the species difference in plasma drug clearance. Rat may serve as an useful animal model to predict (unbound) plasma clearance of drugs in humans.

Entities:  

Mesh:

Year:  1998        PMID: 9755903     DOI: 10.1023/a:1011974226596

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

Review 1.  Interspecies scaling: predicting clearance of drugs in humans. Three different approaches.

Authors:  I Mahmood; J D Balian
Journal:  Xenobiotica       Date:  1996-09       Impact factor: 1.908

2.  Unbound total (plasma) clearance approach in interspecies pharmacokinetics correlation: theophylline-cimetidine interaction.

Authors:  W L Chiou; Y M Choi
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

3.  Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

4.  Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.

Authors:  A Hutchaleelaha; H H Chow; M Mayersohn
Journal:  J Pharm Pharmacol       Date:  1997-02       Impact factor: 3.765

5.  Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs, and humans.

Authors:  H Matsushima; H Kamimura; Y Soeishi; T Watanabe; S Higuchi; M Tsunoo
Journal:  Drug Metab Dispos       Date:  1998-03       Impact factor: 3.922

6.  Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.

Authors:  J H Lin; M Chiba; I W Chen; J A Nishime; K J Vastag
Journal:  Drug Metab Dispos       Date:  1996-12       Impact factor: 3.922

7.  Comparative kinetics of sematilide in four species.

Authors:  P H Hinderling; C Dilea; T Koziol; G Millington
Journal:  Drug Metab Dispos       Date:  1993 Jul-Aug       Impact factor: 3.922

8.  Intravenous verapamil kinetics in rats: marked arteriovenous concentration difference and comparison with humans.

Authors:  P Manitpisitkul; W L Chiou
Journal:  Biopharm Drug Dispos       Date:  1993-10       Impact factor: 1.627

Review 9.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

Review 10.  Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.

Authors:  Y Sawada; M Hanano; Y Sugiyama; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1985-10
View more
  13 in total

1.  Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics.

Authors:  M R Feng; X Lou; R R Brown; A Hutchaleelaha
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens.

Authors:  Gary W Caldwell; David M Ritchie; John A Masucci; William Hageman; Carlos Cotto; Jeffrey Hall; Becki Hasting; William Jones
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

3.  Transgenerational blunting of morphine-induced corticosterone secretion is associated with dysregulated gene expression in male offspring.

Authors:  Fair M Vassoler; Anika M Toorie; Elizabeth M Byrnes
Journal:  Brain Res       Date:  2017-11-10       Impact factor: 3.252

4.  Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches.

Authors:  Kiyomi Ito; J Brian Houston
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

5.  Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.

Authors:  Catherijne A J Knibbe; Klaas P Zuideveld; Leon P H J Aarts; Paul F M Kuks; Meindert Danhof
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

6.  Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.

Authors:  G Robbie; W L Chiou
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

7.  Modelling and PBPK simulation in drug discovery.

Authors:  Hannah M Jones; Iain B Gardner; Kenny J Watson
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

8.  Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?

Authors:  Gary W Caldwell; John A Masucci; Zhengyin Yan; William Hageman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

9.  Adolescent opiate exposure in the female rat induces subtle alterations in maternal care and transgenerational effects on play behavior.

Authors:  Nicole L Johnson; Lindsay Carini; Marian E Schenk; Michelle Stewart; Elizabeth M Byrnes
Journal:  Front Psychiatry       Date:  2011-06-06       Impact factor: 4.157

10.  Glibenclamide induces collagen IV catabolism in high glucose-stimulated mesangial cells.

Authors:  Liping Zhu; Pedro Cortes; Clare Hassett; David W Taube; Jerry Yee
Journal:  Exp Diabetes Res       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.